Future trends in regenerative medicine: 5 years, 10 years and beyond
Thursday 26 August 2021
08:00 [PST] 11:00 [EST] 16:00 [BST]
Staying up to date with the ever-changing field of regenerative medicine and advanced therapies is crucial to ensure you are benefitting from the latest technological innovations, investments and regulatory requirements. However, what if there was a way to look further ahead? Based on Dimensions grants and funding data, this discussion will look at where and how funding is being applied in order to predict future trends and researcher needs. Hosted by RegMedNet Publisher, Freya Leask, an Eppendorf expert and an industry expert will share their insight into where they believe the field might be heading and how vendors and service providers can be ready to address evolving needs.
What will you learn?
• How to use Dimensions on RegMedNet to identify future trends, and emerging institutions/investigators
• Future trends in regenerative medicine and advanced therapies based on recently awards grants and funding data
• Potential future unmet needs and how the industry plans to address them
Who may this interest?
• Biopharmaceutical executives
• Advanced therapy developers
• Cell and gene therapy investors
• Biopharma clinical science professionals
Market Insight Manager Europe, Market Insight and Competitive Intelligence, Vaudaux-Eppendorf AG (Schönenbuch, Switzerland)
Angelika’s educational background is in Chemistry, Biotechnology and Business Strategy. After studying, she travelled around the world for a year and developed her professional career in different life science industries such as medical technology, pharma and biotechnology before she joined Eppendorf (Hamburg, Germany) as Market Insight Manager. Market Insights creates insights based on different data sources to support stakeholders to leverage strategical decisions.
Professor of Stem Cell Sciences, King’s College London (London, UK)
Dusko Ilic is a Senior Lecturer in stem cell science, coordinator of the cross-divisional postgraduate program in stem cells and regenerative medicine, and Head of the Induced Pluripotent Stem Cell Core Facility at King’s College London. He is also Head of the Assisted Conception Unit’s Human Embryonic Laboratories at Guy’s Hospital (London, UK). Dusko is also a member of the editorial board of the journal Regenerative Medicine, where he writes the Industry Report, a regular feature compiling information from non-academic institutions in the field of stem cells and regenerative medicine.